Results 11 to 20 of about 313,149 (366)

HUS and atypical HUS [PDF]

Blood, 2017
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by intravascular hemolysis, thrombocytopenia, and acute kidney failure. HUS is usually categorized as typical, caused by Shiga toxin-producing Escherichia coli (STEC) infection,
Al-Nouri, Allen, Amaral, Ardissino, Arvidsson, Atefi, Atkinson, Berry, Bhakdi, Bhattacharjee, Boltax, Brady, Bresin, Bruneau, Bu, Caires, Campistol, Canalejo, Carson, Chapin, Chien, Cofiell, Cole, Conway, Conway, Coppo, Cornec-Le Gall, de Córdoba, Del Conde, Delvaeye, Dempsey, Devine, Dhakal, Dragon-Durey, Egbor, El-Husseini, Faguer, Fakhouri, Ferreira, Ferreira, Fremeaux-Bacchi, Frimat, George, Gilbert, Gorsuch, Gottschalk, Grabowski, Greenbaum, Hill, Hornung, Hosler, Huber-Lang, Hughson, Hyvärinen, Iida, Ikeda, Jin, Jokiranta, Kang, Karnchanaphanurach, Karpman, Karpman, Karpman, Kavanagh, Keir, Kielstein, Kim, Kourouklaris, Krisinger, Kronbichler, Laurence, Law, Lechner, Lehtinen, Lemaire, Licht, Liszewski, Loirat, Lupu, Manuelian, Martel, Mathew, Matsukuma, Mele, Meri, Morton, Moskovich, Mukhopadhyay, Nakakuma, Nester, Noris, Noris, Noris, Oikonomopoulou, Orth-Höller, Ozaki, Pangburn, Pangburn, Pape, Pecoraro, Pilzer, Podack, Ricklin, Rinder, Rodríguez-Pintó, Roumenina, Ruggenenti, Schutte, Scully, Sethi, Sims, Sinha, Song, Ståhl, Ståhl, Sung, Szilágyi, T. Sakari Jokiranta, Tawadrous, Tedesco, Thomas, Thurman, Toh, Tsai, Tufano, Vasu, Ward, Warwicker, Wehling, Wetsel, Whaley, Wiedmer, Wig, Woodworth, Zipfel, Zipfel   +135 more
core   +7 more sources

Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations [PDF]

American Journal of Transplantation, 2013
Hemolytic uremic syndrome (HUS) is a disease of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. About 90% of cases are secondary to infections by Escherichia coli strains producing Shiga-like toxins (STEC-HUS), while 10% are ...
Alberti, M., Bresin, E., Galbusera, M., Noris, M., Piras, R., Remuzzi, G., Thaiss, F., TRIPODO, Claudio, Valoti, E.   +8 more
core   +2 more sources

Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway. [PDF]

PLoS ONE, 2014
Shiga toxin-producing Escherichia coli (STEC) cause infections in humans ranging from asymptomatic carriage to bloody diarrhoea and haemolytic uremic syndrome (HUS).
Kjersti Haugum, Jostein Johansen, Christina Gabrielsen, Lin T Brandal, Kåre Bergh, David W Ussery, Finn Drabløs, Jan Egil Afset   +7 more
doaj   +2 more sources

Personnel well-being and potentially traumatic COVID-19 pandemic related events (PTES) in the hus helsinki university hospital – baseline results

European Psychiatry, 2021
Introduction A majority of the Finnish COVID-19 pandemic patients have been cared for in the HUS Helsinki University Hospital since March 2020. Objectives June 2020 baseline results of an ongoing prospective cohort study are reported.
T. Laukkala, H. Haravuori, K. Tuisku, K. Junttila, T. Haapa, A. Kujala, E. Pukkala, J. Suvisaari, T. Rosenström, P. Jylhä   +9 more
doaj   +1 more source

Bloody Diarrhea and STEC-HUS in Children: Data from the ItalKid-HUS Network.

Jornal de Pediatria, 2021
OBJECTIVE To analyze the results of an enhanced laboratory-surveillance protocol for bloody diarrhea aimed at identifying children with Shiga Toxin-Producing Escherichia coli (STEC) infection early in the course of the disease towards the early ...
G. Ardissino, C. Vignati, C. Masia, Valentina Capone, R. Colombo, Francesca Tel, L. Daprai, S. Testa, Antonella Dodaro, F. Paglialonga, M. Luini, M. Brigotti, Damiano Picicco, C. Baldioli, F. Pagani, R. Ceruti, P. Tommasi, Ilaria Possenti, D. Cresseri, D. Consonni, G. Montini, M. Arghittu   +21 more
semanticscholar   +1 more source

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)

Pediatric nephrology (Berlin, West), 2021
Hemoconcentration has been identified as a risk factor for a complicated course in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS). This single-center study assesses hemoconcentration and predictors at presentation in STEC-HUS treated ...
S. Loos, Jun Oh, Laura van de Loo, M. Kemper, M. Blohm, Raphael Schild   +5 more
semanticscholar   +1 more source

Efficacy and confounding factors of CT attenuation value differences in distinguishing acute and old vertebral compression fractures: a retrospective study

BMC Musculoskeletal Disorders, 2023
Purpose To evaluate the influence of various factors on CT attenuation values (HUs) of acute and old fracture vertebra, and to determine the efficacy of HU differences (△HUs) in the differentiation of the two type of fractures.
Limin Liang, Ya Wang, Yaya Zhao, Chunyuan Luo, Jianghua Zhu, Xin Zhang, Zhaotao Zhang, Yinquan Ye, Weiwei Deng, Yun Peng, Lianggeng Gong   +10 more
doaj   +1 more source

Low C3 Serum Levels Predict Severe Forms of STEC-HUS With Neurologic Involvement

Frontiers in Medicine, 2020
Background: The correlation between the severity of hemolytic uremic syndrome related to Shiga toxin–producing Escherichia coli (STEC-HUS) and involvement of the complement system has been examined in a small number of studies, with conflicting results ...
G. Netti, Luisa Santangelo, L. Paulucci, G. Piscopo, D. Torres, V. Carbone, P. Giordano, F. Spadaccino, G. Castellano, G. Stallone, L. Gesualdo, M. Chironna, E. Ranieri, M. Giordano   +13 more
semanticscholar   +1 more source

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome [PDF]

, 2016
Background: The role of complement in the atypical form of hemolytic uremic syndrome (aHUS) has been investigated extensively in recent years. As the HUS-associated bacteria Shiga-toxin-producing Escherichia coli (STEC) can evade the complement system ...
Bakker, J.A. (Jaap), Bouts, A.H. (Antonia), Dorresteijn, E.M. (Eiske), Goertz, J. (Joop), Gracchi, V. (Valentina), Heuvel, L.P. (Lambert) van den, Jeronimus-Klaasen, A. (Annelies), Kar, N.C. (Nicole) van de, Keijzer-Veen, M.G. (Mandy), Roos, A. (Anja), van der Molen, R.G. (Renate G.), van der Velden, T.J.A.M. (Thea J. A. M.), van Wijk, J.A.E. (Joanna A. E.), Volokhina, E.B. (Elena), Westra, D.F.   +14 more
core   +9 more sources

IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH

Hepatology, EarlyView., 2022
IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases Abstract Background and Aims Pruritus is associated with multiple liver diseases, particularly those with cholestasis, but the mechanism remains incompletely understood.
Jun Xu, Ya Wang, Mina Khoshdeli, Matt Peach, Jen‐Chieh Chuang, Julie Lin, Wen‐Wei Tsai, Sangeetha Mahadevan, Wesley Minto, Lauri Diehl, Ruchi Gupta, Michael Trauner, Keyur Patel, Mazen Noureddin, Kris V. Kowdley, Aliya Gulamhusein, Christopher L. Bowlus, Ryan S. Huss, Robert P. Myers, Chuhan Chung, Andrew N. Billin   +20 more
wiley   +1 more source